Internal Medicine, Medical Oncology · Pittsburgh, PA
NPI
1497982649
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5115 Centre Ave, Hillman Cancer Center, 2nd Floor
Pittsburgh, PA, 15232
Phone (412) 692-4724
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
338 services
Medicare patients, 2024
136
Average age 72
Drug cost, 2024
$2.0M
554 prescriptions
Company payments, 2025
$127
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa A Burgess was code 99214 (office e&m - established), 85 times for 55 patients. In total Melissa A Burgess billed 338 services in 16 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 85 | 55 | $65.96 | $5,607 |
| 99215 Office E&M - Established | Office | 60 | 34 | $101.75 | $6,105 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 18 | $59.65 | $2,923 |
| 99213 Office E&M - Established | Office | 44 | 31 | $58.85 | $2,589 |
| 99233 Hospital E&M - Subsequent | Facility | 37 | 17 | $89.76 | $3,321 |
| 99205 Office E&M - New | Office | 23 | 23 | $130.99 | $3,013 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $131.06 | $1,835 |
| 99239 Hospital Discharge Management | Facility | 12 | 12 | $86.38 | $1,037 |
By year: 2022 $34K for 423 services; 2023 $29K for 345 services; 2024 $27K for 338 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melissa A Burgess prescribed most often to Medicare patients was Pazopanib Hcl, with 52 prescriptions and refills. In total Melissa A Burgess wrote 554 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pazopanib Hcl Generic | 52 | 52 | Under 11 | $469K |
| Ondansetron Hcl Generic | 43 | 43 | 14 | $737 |
| Imatinib Mesylate Generic | 42 | 42 | Under 11 | $75K |
| Sorafenib Sorafenib Tosylate | 31 | 31 | Under 11 | $132K |
| Gabapentin Generic | 25 | 46 | Under 11 | $788 |
| Levothyroxine Sodium Generic | 24 | 42 | Under 11 | $256 |
| Koselugo Selumetinib Sulfate | 22 | 22 | Under 11 | $277K |
| Ibrance Palbociclib | 19 | 20 | Under 11 | $315K |
| Dexamethasone Generic | 19 | 25 | Under 11 | $280 |
| Sunitinib Malate Generic | 19 | 19 | Under 11 | $85K |
| Pantoprazole Sodium Generic | 14 | 24 | Under 11 | $119 |
| Amlodipine Besylate Generic | 14 | 20 | Under 11 | $132 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 14 | 14 | Under 11 | $872 |
| Xarelto Rivaroxaban | 13 | 13 | Under 11 | $6,893 |
| Anastrozole Generic | 13 | 31 | Under 11 | $219 |
Brand drugs: 92 claims; generic drugs: 462 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa A Burgess $127 ($127 in general payments such as food, travel and fees) from 5 companies. The largest payer was Aadi Bioscience, Inc. with $127.
| Company | Payments | Amount |
|---|---|---|
| Aadi Bioscience, Inc. | 1 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.